US3137631A - Encapsulation in natural products - Google Patents
Encapsulation in natural products Download PDFInfo
- Publication number
- US3137631A US3137631A US856379A US85637959A US3137631A US 3137631 A US3137631 A US 3137631A US 856379 A US856379 A US 856379A US 85637959 A US85637959 A US 85637959A US 3137631 A US3137631 A US 3137631A
- Authority
- US
- United States
- Prior art keywords
- water
- water insoluble
- particles
- albumin
- encapsulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Definitions
- Carbonless Carbon Paper can be made by coating the under side of one sheet of paper with capsules containing a potential color forming reactant. The top side of a second sheet is impregnated with capsules containing the developing reagent. The application of pressure to the pair of sheets in contact causes both types of capsules to rupture, thereby releasing the contents with consequent color development.
- Urea-aldehyde prepolymers are disclosed as being especially suitable for use in such a process but Water soluble resins forming compounds capable of forming melamine, epoxy, thiourea, polyamide, dicyanodiamidealdehyde resins are likewise disclosed as being suitable.
- the water insoluble organic liquids were disclosed as being encapsulated in a plurality of concentric shells made of the same or different resin-forming compounds or in a composite shell composed of a plurality of resin-forming compounds.
- the water insoluble organic liquids could be encapsulated in a water insoluble composite shell derived conjointly from water soluble heat denaturable proteins and water soluble compounds which form cross-linked synthetic resins.
- the objectives set out above, and other valuable objectives are obtained by encapsulating water insoluble organic liquids in water insoluble shells derived from water soluble heat denaturable proteins.
- they are dispersed in an aqueous solution of the water soluble proteins and the proteins are then denatured in the presence of the dispersed particles of water insoluble organic liquids to thereby encapsulate the particles in a water insoluble solid protein shell.
- the proteins are denatured by the application of heat but they can be denatured by use of other kinds of energy as by use of ultraviolet light or ultrasonic sound or by chemicals as by acid or alkali denaturing.
- water insoluble organic liquids may be encapsulated in shells derived from water soluble heat denaturable proteins alone, known cross-linking agents for proteins such as formaldehyde, glyoxal and the like may be used to react with the proteins during the formation of the shell, or after the shell is formed, to impart increased stability to the capsule.
- cross-linking agents for proteins such as formaldehyde, glyoxal and the like may be used to react with the proteins during the formation of the shell, or after the shell is formed, to impart increased stability to the capsule.
- the dissolved water soluble proteins normally have some aflinity for the diluted dispersion of globules of water insoluble organic'liquids and, therefore, tend to concentrate at the interface between the globules and the continuous aqueous phase. In this way, the proteins form a coating around the globules and, when denatured, form a solid water insoluble capsule therearound.
- emulsifying agents which are usually of an oily or fatty nature, may be used to facilitate the formation of an aqueous dispersion.
- Egg albumin has proven especially valuable as a source of heat denaturable protein for, among other things,
- the egg albumin is a good emulsifying agent and the ta water bath. At 65 C.
- water insoluble organic liquid can be easily dispersed in the aqueous body'in the presence of egg albumin by mechanical agitation with a conventional high speed mixer.
- Other water soluble and heat denaturable proteins I suitable for use in the process of this invention include blood, other albumins, blood plasma, globulin, myosin,
- the water soluble proteins maybe effectively and economically denatured by the application of heat tothereby form a I water insoluble solid shell around the water insoluble liquid.
- other forms of energy or chemical means may be'used to denature the proteins and render them water insoluble as by the use of ultraviolet light, ultrasonic sound or by the use of chemicals such as acid or alkali denaturants.
- the present invention relates to a process for encapsulating, or coating, particles 'of water insoluble organic liquids'withdenatured and water a I insolubilized proteins and to. the resulting encapsulated I product.
- the invention' relates to a process involving dispersing particles of a water insoluble organic compound in anaqueous solution of a water soluble heat denaturable protein-thereby applying to and absorbing on the surfaces of the dispersed particles the heat denaturable protein and denaturing the protein on the surfaces of the' particles until it'becornes substantially water insoluble, i.e., cross-linked.
- the dispersion of the water insoluble organic liquid in the aqueous media may be facilitated by using I a water soluble thickening agent, or an agent imparting colloidality to the media.
- I a water soluble thickening agent
- Compounds found very useful as thickening agents include methyl cellulose, hy-
- these colloids are water soluble, they also have some affinity for the Water insoluble organic liquid.
- ,Thus thesefcolloids fa cilitate the formation ofv an aqueous dispersion of the organic liquid and have a tendency to concentrate at the interface between the dispersed Water insoluble organic liquid and the continuous aqueous phase. In this way,
- EXAMPLE 6 Encapsulation a Mixture of Essential Oils in Urea- F ormaldelzyde, Albumin and Barium Sulfate Fifty (50) ml. of water was used to dissolve grams of urea, 12.5 grams of 37% aqueous formaldehyde, and 2.5 grams of sodium sulfate. Ten grams of the perfume oil of Example 5 and 1 gram of a mixture of mono and dilauryl phosphates were stirred into the aqueous solution while stirring with a stirrer rotating at 200-300 r.p.m. Then 5 grams of egg albumin in 25 ml. of water was added, and the stirring at 200-300 r.p.m. continued for a half hour.
- Colloidal silica or powdered titanium dioxide could be added, at this point in the procedure, in lieu of barium chloride.
- EXAMPLE 7 Encapsulation of Normally Solid Volatile Compounds
- 50 grams of a 10% aqueous egg albumin solution was added and the stirring continued for an equal period.
- the resulting suspension of capsules may be washed free of mother liquid or used as such for spray-drying, brush or blade application to the surface of paper or other nonwoven or woven fibrous materials.
- This preparation can be made odor free by air-drying the filtered, or centrifuged, capsules overnight in an oven kept at 50 to 60 C.
- the principles of this invention can be applied to the encapsulation of any ingredient which has a greater affinity for the water insoluble organic liquid than it has for Water.
- the water insoluble organic compound is an oil any ingredient may be kept in dispersion in the dispersed oil phase which is more lipophilic than hydrophilic.
- Predominantly lipophilic emulsifiers could be used to assist in the dispersion of the substances in the oil phase.
- the same principle may be used to encapsulate solids which are insoluble both in the oil phase and in the water.
- a liquid phase process for encapsulating a water insoluble organic liquid which comprises dispersing finely divided particles of said liquid and a solution of egg albumin in a body of water, heat denaturing said albumin until it forms a substantially water insoluble denatured egg albumin coating around said particles while said particles are dispersed in said body of water thereby encapsulating the particles in a solid shell and separating the encapsulated particles from the body of water.
- a liquid phase process for encapsulating a water insoluble organic liquid which comprises dispersing finely divided particles of said liquid and a solution of a plurality ofwater soluble cross-linking resin-forming compounds in a' body ofwater, at least one of said resin-forming compounds being a heat denaturable albumin, denaturing said albumin by the application of heat and polymerizing any remaining resin-forming compounds until they deposit solution of a water soluble heat denaturable albumin in v a body of Water, applying heat to said body of water untilsaid albumin deposits a substantially water insoluble heat denatured albumin coating around said particles while said particles are dispersed in said body of Water thereby encapsulating particles in' a solid shell and separating the encapsulated particles from the body Of'WZlIGI".
- Finely divided particlesof a perfume oil encapsulated in a solid shell of'a heat denatured egg albumin 8. Finely divided particlesof a perfume oil encapsulated in a solid shell of'a heat denatured egg albumin.
- a fibrous tissue having incorporated therein finely divided particles of a Water insoluble but Volatile liquid encapsulated in a heat denatured alb umin shell derived from, a Water soluble albumin.
Description
3,137,631 EN CAPSULATION 1N NATURAL PRODUCTS Saul Soloway, New Rochelle, N.Y., assignor, by mesne assignments, to Faberge, Inc., Ridgefield, NJL, a corporation of Delaware No Drawing. Filed Dec. 1, 1959, Ser. No. 856,379 11 Claims. (Cl. 167-83) This invention relates to encapsulating water insoluble organic liquids and the resulting products.
Those liquids, compounds or mixtures, which have appreciable vapor pressures or which are subject to chemical change by reaction with some atmospheric constituent, may be protected from volatilization or reaction with the environment by enclosure in inert capsules. Solids, having similar properties, may be dissolved in appropriate liquids and then encapsulated as solutions. Some of the volatile essential oils of commerce which could be encapsulated to advantage for applications to be discussed later are: oils of lemon, orange, anise, pine, almond, thyme, rose, jasmine and citronella. In fact one might include all the oils used in the perfume, flavor, food and allied industries. Specific types of compounds such as aldehydes, olefins, acetylenes, mercaptans, amines, ethers and phenols are readily protected against autoxidation by encapsulation. Protection of oxygen sensitive compounds without the use of an anti oxidant is particularly desirable for the preservation of animal fats, vegetable oils and vitamins such as A, E, and C. The general use of anti oxidants in these instances is viewed as that of a necessary contaminant.
It is often desirable to envelop substances, which may or may not be stable, in capsules which are frangible. Such capsules may be integrated into a fabric, woven or non-woven, so that the application of pressure will release the material. This concept constitutes a novel Way of dispensing perfume and certain types of medication. The encapsulation of such voltile compounds as menthol, camphor, pine oil, oil of eucalyptus, etc. offers a most convenient mode of dispensing alleviants for respiratory disease.
The separate encapsulation of two or more potential reactants offers many possibilities. Carbonless Carbon Paper can be made by coating the under side of one sheet of paper with capsules containing a potential color forming reactant. The top side of a second sheet is impregnated with capsules containing the developing reagent. The application of pressure to the pair of sheets in contact causes both types of capsules to rupture, thereby releasing the contents with consequent color development.
For the reasons given above, many attempts have been made to encapsulate organic substances which are in soluble in Water and are liquid at temperatures at which water is liquid. (Such substances are hereinafter called water insoluble organic liquids.) For example, efforts have been made to encapsulate such substances in gels or encompass them in waxes. Such efforts have not been adequately successful because of rapid leakage through the gel and structural weakness of the wax. Waxes are also readily dissolved by most organic oils and hence are only limited to use for encapsulating polar liquids.
' It is a principal object of this invention to overcome, or at least abate the drawbacks heretofore associated with encapsulating water insoluble organic liquids. It is a special object of this invention to provide an encapsulating process which can be carried out at the mild temperature at which water is liquid. It is a special object of this invention to encapsulate volatile substances such as perfume coils or substances which favorably affect respiration. Other objects and features of the invention A United States Patent will become apparent from the more detailed description of the invention which follows.
In my copending application Serial No. 846,535, filed October 15, 1959, now abandoned, it was disclosed that the aforesaid objectives can be obtained by encapsulating water insoluble liquids, such as mentioned above, in solid shells of cross-linked synthetic resins. These encapsulating cross-linked synthetic resin shells, as is known, are water insoluble and are insoluble in usual organic solvents. In order to encapsulate the water insoluble organic liquids in the synthetic crosslinked resin shells, the water insoluble organic liquid was dispersed in an aqueous solution of compounds capable of forming cross-linked synthetic resins by the application of heat or catalyst or both and then the resinforming compounds were polymerized in the presence of the dispersed Water insoluble liquids to thereby encapsulate them. Urea-aldehyde prepolymers are disclosed as being especially suitable for use in such a process but Water soluble resins forming compounds capable of forming melamine, epoxy, thiourea, polyamide, dicyanodiamidealdehyde resins are likewise disclosed as being suitable.
In special embodiments of that invention, the water insoluble organic liquids were disclosed as being encapsulated in a plurality of concentric shells made of the same or different resin-forming compounds or in a composite shell composed of a plurality of resin-forming compounds. In a particular embodiment of that invention, it was disclosed that the water insoluble organic liquids could be encapsulated in a water insoluble composite shell derived conjointly from water soluble heat denaturable proteins and water soluble compounds which form cross-linked synthetic resins.
In accordance with this invention, the objectives set out above, and other valuable objectives, are obtained by encapsulating water insoluble organic liquids in water insoluble shells derived from water soluble heat denaturable proteins. In order to encapsulate the water insoluble organic liquids, they are dispersed in an aqueous solution of the water soluble proteins and the proteins are then denatured in the presence of the dispersed particles of water insoluble organic liquids to thereby encapsulate the particles in a water insoluble solid protein shell. In an important method of practicing the invention, the proteins are denatured by the application of heat but they can be denatured by use of other kinds of energy as by use of ultraviolet light or ultrasonic sound or by chemicals as by acid or alkali denaturing. Although valuable substances in capsule form may be obtained by encapsulating the Water insoluble organic liquids in shells derived from water soluble heat denaturable proteins alone, known cross-linking agents for proteins such as formaldehyde, glyoxal and the like may be used to react with the proteins during the formation of the shell, or after the shell is formed, to impart increased stability to the capsule. By following the process hereof water insoluble organic liquids are encapsulated in a substantially impermeable shell of a denatured denaturable protein.
While no theory is necessary to an understanding of this invention, it is felt that the dissolved water soluble proteins normally have some aflinity for the diluted dispersion of globules of water insoluble organic'liquids and, therefore, tend to concentrate at the interface between the globules and the continuous aqueous phase. In this way, the proteins form a coating around the globules and, when denatured, form a solid water insoluble capsule therearound.
If desired, known emulsifying agents, which are usually of an oily or fatty nature, may be used to facilitate the formation of an aqueous dispersion.
Egg albumin has proven especially valuable as a source of heat denaturable protein for, among other things,
the egg albumin is a good emulsifying agent and the ta water bath. At 65 C.
water insoluble organic liquid can be easily dispersed in the aqueous body'in the presence of egg albumin by mechanical agitation with a conventional high speed mixer. Other water soluble and heat denaturable proteins I suitable for use in the process of this invention include blood, other albumins, blood plasma, globulin, myosin,
glutelin, excelsin, edestin, arachin, casein and like water soluble proteins and their mixtures which become denatured by heating. I t I In the encapsulating process disclosed above, the water soluble proteins maybe effectively and economically denatured by the application of heat tothereby form a I water insoluble solid shell around the water insoluble liquid. On the other hand, other forms of energy or chemical means may be'used to denature the proteins and render them water insoluble as by the use of ultraviolet light, ultrasonic sound or by the use of chemicals such as acid or alkali denaturants.
Thus, broadly considered, the present invention relates to a process for encapsulating, or coating, particles 'of water insoluble organic liquids'withdenatured and water a I insolubilized proteins and to. the resulting encapsulated I product. In accordance with a more limited aspect of the invention, the invention'relates to a process involving dispersing particles of a water insoluble organic compound in anaqueous solution of a water soluble heat denaturable protein-thereby applying to and absorbing on the surfaces of the dispersed particles the heat denaturable protein and denaturing the protein on the surfaces of the' particles until it'becornes substantially water insoluble, i.e., cross-linked.
If desired, the dispersion of the water insoluble organic liquid in the aqueous media may be facilitated by using I a water soluble thickening agent, or an agent imparting colloidality to the media. Compounds found very useful as thickening agents include methyl cellulose, hy-
droxyethyl cellulose and sodium carboxymethyl cellulose V and similar compounds known to improve the sus end, ing capacity of aqueous media. Although these colloids are water soluble, they also have some affinity for the Water insoluble organic liquid. ,Thus, thesefcolloids fa cilitate the formation ofv an aqueous dispersion of the organic liquid and have a tendency to concentrate at the interface between the dispersed Water insoluble organic liquid and the continuous aqueous phase. In this way,
the encapsulation is aided.
In many instances sequential coating of the dispersed water insoluble organic liquid particles gives an importantly improved encapsulated material enclosed in concentric shells. In this way, two or more concentric shells composed of water insolubilized proteins may be formed around the water insoluble organic liquid as disclosed herein or concentric shells respectively composed of water insolubilized proteins and cross-linked resins may serve as fillers for any imperfectly formed capsules containing micro cracks. I I
The meaning and significance of the invention will become even more apparent from the following illustrative examples. a
EXAMPLE I I Methyl'Benzoate Encapsulated in Egg'Albumin I Twenty-seven (27) grams of'methyl 'benzoate were added to a solution of ,ZO grams of egg'albumin in' 230 ml. of water at room temperature. The mixture was stirred at approximately 300 r.p.m. and heated on I asuspension in benzene.
ture waspoured into 800 ml. of tap water. Two solid phases formed. One was lighter and the otherhe'avier than the aqueous medium. The less dense solid was washed extensively with methanol. The heavier solid was washed with'water several times by decantation y Both washed solids were dried at 50C. with air'cir vculating through the oven; The odorless mass liberated the odor of methyl benzoate on rubbingthe solid par- 'ti cles against'one another. I
' I EXAMPLE 2 Pinene Encapsulated in Egg Albumin One hundred lOO) grams of pinene were emulsified I I in a solution of'45 grams of egg albumin dissolved in A 900 grams of water. The resulting suspension washeated on a water bath at a rateof 2 to 3 degrees O per minute;
The main batch "of solids was split into' t wo parts One was treated with '30 grams of 37%aqueous form-" aldehyde and the other with 40 grams of 30% glyoxal. Both batches were heated to C. for 15 minutes.
The separation and @drying'steps Were thesame asde scribed in the first"preparation; The resulting dried glyoxal treated material was quite hard and difficultto break by crushing with the fingers. yielded odor on the applicationof frictional forces. Q
EXAMPLIEIISI' Encapsulation of Born'yl Acetate in Bornyl acetate wassuccessfully encapsulated inegg I albumin in weight ratiosfof 1:1 and 2:1 and thereafter treated with formaldehyde by following the procedure I as disclosed in Example 2. An experiment using a3 to 1 ratio had a tendency to oil out. I I s v In these preparations the intial oil dispersion was passed through a colloid mill before theheating step. The final preparationconsisted'of particles of about 1 cm. in diameter. These were broken up in an osterizer as The separated particles were odor free on drying, but
ticle friction. a
- EXAMPLE 4 readily released the odor of bornyl acetate on inter par I V Encapsulation of:-'B 0rnyl Acetate. in Albumin and "Urea- I Formaldehyde Polymer Forty-five; (45) grams of bornyl acetatewere emulsified in a solution of 45 grams of egg albumin dissolved in 900 grams of water. The resulting dispersion was passed through a colloidal mill and the suspension was then heated on a water bath at a rate of 2 to'3 degrees C .'PI' minute. When the temperature reached C., it was held:
[phosphates were dissolved in 25 "grams of an oily-mass I consisting of a perfume oil'prepared from2 0% of each there for ten minutes. After the coagulation was completed, 10'grams of urea, 25. ml. of 35% formaldehyde,
and 1 mol of concentrated hydrochloric acid were'added I in successionand the heating was continued on the water bath until solid urea-formaldehyde resin wasno longer formed. The encapsulated solids were separated in the same .manner as in the preceding examples.
' EXAMPLE .5
Encapsulation of a Mixture of Essential Oils l Formaldehyde and Albumin Two (2) grams. of 'a mixture of mono: and' 'dilauryl Ureaof the following natural oils and synthetic compounds} B-phenyl ethylalcohol, 'geraniol, linalool, altarof 'Rose coagulation beganto set in. r After the temperature reached C;, thereaction mix I When the temperature reached 75 C., it was held there for ten minutes.
A small portion of theformed solids Wcresep'arated by decantation and washed with water and, acetone. This, prod'uct'yielded no pinene odor on crushing.
Both preparations I j 8 and oil of Neroli. This solution was added to a solution of 20 grams of urea in 300 ml. of water, followed by an addition of 50 ml. of 37% formaldehyde. While the above dispersion was being stirred, a solution of 10 grams of alubumin in 100 ml. of water was added dropwise over a period of 2 minutes. The albumin caused the oil to become more finely dispersed and seemed to coagulate around the droplets at room temperature. The preparation was heated in the manner as described in the preceding examples, filtered, Washed with water and isopropanol and dried. Stable capsules of the perfume oil were obtained.
EXAMPLE 6 Encapsulation a Mixture of Essential Oils in Urea- F ormaldelzyde, Albumin and Barium Sulfate Fifty (50) ml. of water was used to dissolve grams of urea, 12.5 grams of 37% aqueous formaldehyde, and 2.5 grams of sodium sulfate. Ten grams of the perfume oil of Example 5 and 1 gram of a mixture of mono and dilauryl phosphates were stirred into the aqueous solution while stirring with a stirrer rotating at 200-300 r.p.m. Then 5 grams of egg albumin in 25 ml. of water was added, and the stirring at 200-300 r.p.m. continued for a half hour. After reaction period induced by heating the reaction mass, the urea formaldehyde resin and the denatured egg albumin were formed into a shell around the oil. A dilute barium chloride solution was then added to form a final coat of barium sulfate with the aqueous sulfate ion present. A very stable encapsulated perfume oil was obtained encased in the cross-linked resins and the coating of barium sulfate.
Colloidal silica or powdered titanium dioxide could be added, at this point in the procedure, in lieu of barium chloride.
EXAMPLE 7 Encapsulation of Normally Solid Volatile Compounds A liquid mixture of 30 grams'of menthol, 10 grams of camphor, and 10 grams of bornyl acetate was stirred and dispersed in 50 grams of 10% methyl cellulose c.p.s.) in water. Fifty grams of an aqueous acidic colloidal solution containing 10% of an urea-formaldehyde prepolymer was added to this dispersion. After stirring, at room temperature, for a half hour, 50 grams of a 10% aqueous egg albumin solution was added and the stirring continued for an equal period. The resulting suspension of capsules may be washed free of mother liquid or used as such for spray-drying, brush or blade application to the surface of paper or other nonwoven or woven fibrous materials.
This preparation can be made odor free by air-drying the filtered, or centrifuged, capsules overnight in an oven kept at 50 to 60 C.
Also, where it is desired to obtain an intimate admixture of the encapsulated material and the carrier, such as in the production of paper for producing a paper handkerchief it is possible to introduce the capsules into the carrier during its manufacture such as by mixing together an aqueous paper pulp and the aqueous suspension of capsules during the processing of the pulp to paper.
A very satisfactory product for the alleviation of colds has been obtained by incorporating the capsules of this example in non-woven paper tissue. Other types of nonwoven fibrous tissue may be used in the same way.
While the preceding examples have related to encapsulating volatile water insoluble organic liquids, especially perfume oils and aromatics, it will be understood that other types of water insoluble liquids, mentioned herein, may be encapsulated by following the same procedure. Also, water soluble heat hardenable proteins may be dissolved in the aqueous medium in place of the egg albumin in equivalent proportions, to encapsulate the water insoluble organic liquids in the other types of denatured proteins derived from the other proteins disclosed above. Likewise, other resins typified by those disclosed hereinbefore, may be substituted for the urea-formaldehyde resins of the examples to modify the denatured protein capsules.
It is apparent from the foregoing discussion that encapsulation and encapsulate has reference to the formation of solid shells or capsules around the dispersed globules of water insoluble organic liquids. As pointed out in the body of the specification and in the specific examples, a dilute suspension of the organic liquid is first formed in an aqueous solution of the heat denaturable protein. These water soluble heat denaturable proteins can concentrate at the oil-water interface where they are insolubilized and formed into a denatured protein shell encapsulating the water insoluble oil by the action of heat or by other methods set out above.
It will be understood the foregoing general description as complemented by the specific examples has served to illustrate the invention and its principles. However, many modifications and variations in the details of the disclosure will occur to those skilled in the art to which the invention appertains and still remain within the principles of the invention and its scope. For instance, the illustrative embodiments of the invention have been concerned primarily with encapsulating water insoluble organic compounds which are liquid at temperatures at which water is liquid and with encapsulating such compounds containing dissolved, or otherwise dispersed therein, additional ingredients which are readily dispersed in the water insoluble organic compounds. It will be apparent, however, that the principles of the invention can be applied to encapsulating ingredients which are more difiicult to disperse in the water insoluble organic liquids. Broadly considered, the principles of this invention can be applied to the encapsulation of any ingredient which has a greater affinity for the water insoluble organic liquid than it has for Water. For example, when the water insoluble organic compound is an oil any ingredient may be kept in dispersion in the dispersed oil phase which is more lipophilic than hydrophilic. Predominantly lipophilic emulsifiers could be used to assist in the dispersion of the substances in the oil phase. The same principle may be used to encapsulate solids which are insoluble both in the oil phase and in the water. For example, the absorption, or coating, of a substance onto the solid particles being dispersed in the oil phase which has an amnity for oil and then dispersing the solid in the oil before it is, in turn, dispersed in the water for encapsulation. This latter principle can be used even to disperse and then encapsulate water soluble solids.
Thus, it will be seen the invention is capable of many modifications as to details and still remain within the scope of the invention as defined in the claims.
What is claimed is:
1. A liquid phase process for encapsulating a water insoluble organic liquid, which comprises dispersing finely divided particles of said liquid and a solution of a water soluble heat denaturable albumin in a body of water, denaturing said albumin by the application of heat until it forms a substantially water insoluble denatured protein coating around said particles while said particles are dispersed in said body of Water thereby encapsulating the particles in a solid shell and separating the encapsulated particles from the body of water.
2. A liquid phase process for encapsulating a water insoluble organic liquid, which comprises dispersing finely divided particles of said liquid and a solution of egg albumin in a body of water, heat denaturing said albumin until it forms a substantially water insoluble denatured egg albumin coating around said particles while said particles are dispersed in said body of water thereby encapsulating the particles in a solid shell and separating the encapsulated particles from the body of water.
'3. A liquid phase process for encapsulating a water insoluble organic liquid, which comprises dispersing finely divided particles of said liquid and a solution of a plurality ofwater soluble cross-linking resin-forming compounds in a' body ofwater, at least one of said resin-forming compounds being a heat denaturable albumin, denaturing said albumin by the application of heat and polymerizing any remaining resin-forming compounds until they deposit solution of a water soluble heat denaturable albumin in v a body of Water, applying heat to said body of water untilsaid albumin deposits a substantially water insoluble heat denatured albumin coating around said particles while said particles are dispersed in said body of Water thereby encapsulating particles in' a solid shell and separating the encapsulated particles from the body Of'WZlIGI". 5. A plurality of small discrete particles of a Water insoluble organic liquid encapsulated in a Water insoluble and substantially impermeable solid shell of a heat denatured albumin. 6. Finely divided particles of a water insoluble aromatic liquid encapsulated in a solid shell of a heat denatured albumin.
7. Finely divided particles of a liquid odoriferous substance encapsulated in a solid shell of a heat denatured egg albumin. g i V V,
8. Finely divided particlesof a perfume oil encapsulated in a solid shell of'a heat denatured egg albumin.
9.' A fibrous tissue having incorporated therein finely divided particles of a Water insoluble but Volatile liquid encapsulated in a heat denatured alb umin shell derived from, a Water soluble albumin.
10'. A plurality of small'discrete, particles ofa water insoluble organic liquid encapsulated in a water insoluble and substantially impermeable composite solid shell coma prising a heat denatured" albumin, "and across-linked imino synthetic resin.
7 11. l A paperltissue having incorporated therein a Water. insoluble but volatile decongestant encapsulatedin. a solid shell of aheat denatured water soluble albumin.
References Cited the file of this patent I IE sT riss PATENTS 2,491,475 Bogin Dec. 20, 1949 2,656,298 Loewe Oct. 20, 1953 2,797,201 Ve'atch et a1. June 25; 1957- 2,80Q,457 Green July 23; 1957 2,800,458 Green July 23,1957 2,870,062 Stanley, et a1. Jan. 20,- 1960 a 2,969,330 Brynko -i Ian, 24, 1961" Katchen et a1. June 2 6, 1962
Claims (1)
1. A LIQUID PHASE PROCESS FOR ENCAPSULATING A WATER INSOLUBLE ORGANIC LIQUID, WHICH COMPRISES DISPERSING FINELY DIVIDED PARTICLES OF SAID LIQUID AND A SOLUTION OF A WATER SOLUBLE HEAT DENATURABLE ALBUMIN IN A BODY OF WATER, DENATURING SAID ALBUMIN BY TE APPLICATION OF HEAT UNTIL IT FORMS A SUBSTANTIALLY WATER INSOLUBLE DENATURED PROTEIN COATING AROND SAID PARTICLES WHILE SAID PARTICLES ARE DISPERSED IN SAID BODY OF WATER THEREBY ENCAPSULATING THE PARTICLES IN A SOLID SHELL AND SEPARATING THE ENCAPSULATED PARTICLES FROM THE BODY OF WATER.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US856379A US3137631A (en) | 1959-12-01 | 1959-12-01 | Encapsulation in natural products |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US856379A US3137631A (en) | 1959-12-01 | 1959-12-01 | Encapsulation in natural products |
Publications (1)
Publication Number | Publication Date |
---|---|
US3137631A true US3137631A (en) | 1964-06-16 |
Family
ID=25323468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US856379A Expired - Lifetime US3137631A (en) | 1959-12-01 | 1959-12-01 | Encapsulation in natural products |
Country Status (1)
Country | Link |
---|---|
US (1) | US3137631A (en) |
Cited By (132)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3257267A (en) * | 1965-05-19 | 1966-06-21 | Harold R Hay | Retarding liberation of an additament in forming a fibrous web by embedding the additament in a gel matrix prior to addition to the fibers |
US3293114A (en) * | 1964-04-03 | 1966-12-20 | Dow Chemical Co | Method of forming paper containing gaseous filled spheres of thermoplastic resins and paper thereof |
US3384536A (en) * | 1965-03-24 | 1968-05-21 | Ncr Co | Process for forming fibrous sheets containing limited penetration of additaments within the sheet and sheets thereof |
US3406119A (en) * | 1965-03-05 | 1968-10-15 | Keuffel & Esser Co | Encapsulation |
US3490454A (en) * | 1966-10-21 | 1970-01-20 | United Merchants & Mfg | Catamenial products having a coating of rupturable microcapsules containing medicants |
US3515070A (en) * | 1968-05-15 | 1970-06-02 | Us Army | Chemiluminescent peraminoethylene positioned within a brittle capsule |
US3516846A (en) * | 1969-11-18 | 1970-06-23 | Minnesota Mining & Mfg | Microcapsule-containing paper |
US3516941A (en) * | 1966-07-25 | 1970-06-23 | Minnesota Mining & Mfg | Microcapsules and process of making |
US3521637A (en) * | 1967-11-28 | 1970-07-28 | Nelson J Waterbury | Tampon or similar sanitary napkin containing vitamin a |
FR2033293A1 (en) * | 1969-02-04 | 1970-12-04 | Oreal | |
US3623659A (en) * | 1969-12-29 | 1971-11-30 | Ncr Co | Articles of manufacture containing encapsulated, vaporizable core material |
US3663685A (en) * | 1968-04-01 | 1972-05-16 | Minnesota Mining & Mfg | Biodegradable radioactive particles |
US3669899A (en) * | 1969-04-29 | 1972-06-13 | Us Plywood Champ Papers Inc | Microcapsular opacifier system |
US3720579A (en) * | 1968-12-23 | 1973-03-13 | Champion Int Corp | Fibrous substrates with microcapsular opacifiers |
US3816169A (en) * | 1969-04-29 | 1974-06-11 | Champion Int Corp | Fibrous and non-fibrous substrates coated with microcapsular pacifier system and the production of such coated substrates |
US3886084A (en) * | 1966-09-29 | 1975-05-27 | Champion Int Corp | Microencapsulation system |
US3911099A (en) * | 1974-01-23 | 1975-10-07 | Defoney Brenman Mayes & Baron | Long-acting articles for oral delivery and process |
US3937668A (en) * | 1970-07-15 | 1976-02-10 | Ilse Zolle | Method for incorporating substances into protein microspheres |
USB498208I5 (en) * | 1974-08-16 | 1976-04-13 | ||
US3957964A (en) * | 1974-01-30 | 1976-05-18 | Colgate-Palmolive Company | Dentifrice containing encapsulated flavoring |
US3978204A (en) * | 1969-02-04 | 1976-08-31 | L'oreal | Cosmetic composition containing microencapsulated solvents for nail enamel |
US4039653A (en) * | 1974-01-23 | 1977-08-02 | Defoney, Brenman, Mayes & Baron | Long-acting articles for oral delivery and process |
US4105823A (en) * | 1975-11-26 | 1978-08-08 | Wiggins Teape Limited | Microcapsules, method for their preparation, and sheet material carrying microcapsules |
US4115534A (en) * | 1976-08-19 | 1978-09-19 | Minnesota Mining And Manufacturing Company | In vitro diagnostic test |
US4138362A (en) * | 1975-03-24 | 1979-02-06 | Champion International Corporation | Formation of microcapsules by interfacial cross-linking, microcapsules produced, and microcapsular dispersion |
US4138505A (en) * | 1976-10-28 | 1979-02-06 | Blue Wing Corporation | Nutrient compositions derived from animal blood solids and process for producing same |
WO1979000111A1 (en) * | 1977-08-25 | 1979-03-08 | Blue Wing Corp | Improved lipid-containing feed supplements and foodstuffs |
US4145184A (en) * | 1975-11-28 | 1979-03-20 | The Procter & Gamble Company | Detergent composition containing encapsulated perfume |
US4152272A (en) * | 1976-10-29 | 1979-05-01 | The Procter & Gamble Company | Fabric conditioning composition |
US4169804A (en) * | 1976-08-19 | 1979-10-02 | Minnesota Mining And Manufacturing Company | Magnetically responsive composite microparticle |
US4184495A (en) * | 1976-04-07 | 1980-01-22 | Philip Morris, Inc. | Process for incorporating flavorant into cellulosic substrates and products produced thereby |
US4217369A (en) * | 1976-08-09 | 1980-08-12 | The Pillsbury Company | Moisture resistant nut-like food composition |
US4217370A (en) * | 1977-08-25 | 1980-08-12 | Blue Wing Corporation | Lipid-containing feed supplements and foodstuffs |
US4225620A (en) * | 1977-08-26 | 1980-09-30 | Blue Wing Corporation | Method for feeding ruminant animals |
US4248899A (en) * | 1979-02-26 | 1981-02-03 | The United States Of America As Represented By The Secretary Of Agriculture | Protected feeds for ruminants |
US4273672A (en) * | 1971-08-23 | 1981-06-16 | Champion International Corporation | Microencapsulation process |
US4331654A (en) * | 1980-06-13 | 1982-05-25 | Eli Lilly And Company | Magnetically-localizable, biodegradable lipid microspheres |
WO1982001994A1 (en) * | 1980-12-11 | 1982-06-24 | Univ Ohio | Implants,microbeads,microcapsules,and method for their preparation |
US4357259A (en) * | 1977-08-01 | 1982-11-02 | Northwestern University | Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres |
US4388352A (en) * | 1981-08-03 | 1983-06-14 | Board Of Regents, University Of Washington | Method for preparing a controlled release composition |
US4396670A (en) * | 1980-04-08 | 1983-08-02 | The Wiggins Teape Group Limited | Process for the production of microcapsules |
EP0093668A1 (en) * | 1982-05-04 | 1983-11-09 | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) | Microcapsules having a wall of reticulately bound milk proteins, and method for their preparation |
WO1984000304A1 (en) * | 1982-07-08 | 1984-02-02 | Mitchell Harman | Injectible sustained release dosage cylinders |
WO1985000011A1 (en) * | 1983-06-17 | 1985-01-03 | Univ Miami | Microdroplets of water-insoluble drugs |
US4514461A (en) * | 1981-08-10 | 1985-04-30 | Woo Yen Kong | Fragrance impregnated fabric |
US4608263A (en) * | 1984-09-11 | 1986-08-26 | The Quaker Oats Company | Method for making flavored dipeptide sweetened comestible |
US4660763A (en) * | 1985-09-11 | 1987-04-28 | S. C. Johnson & Son, Inc. | Vapor-dispensing device |
US4666641A (en) * | 1984-06-05 | 1987-05-19 | Universite Paris-Sud (Paris Xi) | Preparation of biodegradable microcapsules based on serum albumin |
US4715390A (en) * | 1985-11-19 | 1987-12-29 | Philip Morris Incorporated | Matrix entrapment of flavorings for smoking articles |
US4729792A (en) * | 1985-11-08 | 1988-03-08 | The Standard Register Company | Microcapsules, printing inks and their production |
USRE32713E (en) * | 1980-03-17 | 1988-07-12 | Capsule impregnated fabric | |
US4798786A (en) * | 1982-05-06 | 1989-01-17 | Stolle Research And Development Corporation | Living cells encapsulated in crosslinked protein |
EP0349428A1 (en) * | 1988-06-30 | 1990-01-03 | Centre National De La Recherche Scientifique (Cnrs) | Process for preparing colloidal dispersive protein systems in the shape of nanoparticles |
US4898780A (en) * | 1985-11-08 | 1990-02-06 | The Standard Register Company | Production of microcapsules |
US4956129A (en) * | 1984-03-30 | 1990-09-11 | Ici Americas Inc. | Microencapsulation process |
WO1991005482A1 (en) * | 1989-10-13 | 1991-05-02 | The Regents Of The University Of California | Method to produce unsaturated milk fat and meat from ruminant animals |
US5023080A (en) * | 1988-06-17 | 1991-06-11 | Basic Bio Systems, Inc. | Time release protein |
US5055300A (en) * | 1988-06-17 | 1991-10-08 | Basic Bio Systems, Inc. | Time release protein |
US5074902A (en) * | 1990-07-30 | 1991-12-24 | Connick Jr William J | Granular products containing fungi encapsulated in a wheat gluten matrix for biological control of weeds |
US5132117A (en) * | 1990-01-11 | 1992-07-21 | Temple University | Aqueous core microcapsules and method for their preparation |
US5143737A (en) * | 1989-10-13 | 1992-09-01 | The Regents Of The University Of California | Method to produce unsaturated milk fat and meat from ruminant animals |
US5383862A (en) * | 1990-02-03 | 1995-01-24 | Telemedysis Inc | Method and device for enveloping and disinfecting of sharp instruments |
US5418010A (en) * | 1990-10-05 | 1995-05-23 | Griffith Laboratories Worldwide, Inc. | Microencapsulation process |
US5549903A (en) * | 1994-03-03 | 1996-08-27 | Ben Gurion University Of Negev Research & Development Aurthority | Microencapsulated composition containing chlorpyrifos or endosulfsan |
US5578709A (en) * | 1993-03-09 | 1996-11-26 | Middlesex Sciences, Inc. | Macromolecular microparticles and methods of production |
US5607754A (en) * | 1993-11-12 | 1997-03-04 | Kimberly-Clark Corporation | Paper web product and method for manufacturing same |
US5686113A (en) * | 1995-03-21 | 1997-11-11 | Temple University Of The Commonwealth System Of Higher Education | Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses |
US6090925A (en) * | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6174514B1 (en) * | 1999-04-12 | 2001-01-16 | Fuisz Technologies Ltd. | Breath Freshening chewing gum with encapsulations |
US20020098573A1 (en) * | 1996-10-30 | 2002-07-25 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
US20020119199A1 (en) * | 1996-08-22 | 2002-08-29 | Indu Parikh | Fenofibrate microparticles |
US20020172690A1 (en) * | 1998-12-22 | 2002-11-21 | Calvert Jay G. | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US20030013693A1 (en) * | 1998-02-11 | 2003-01-16 | Rtp Pharma Inc. | Method and composition for treatment of inflammatory conditions |
US6531156B1 (en) | 1994-04-15 | 2003-03-11 | Temple University | Aqueous solven encapsulation method, apparatus and microcapsules |
US20030049274A1 (en) * | 1999-03-08 | 2003-03-13 | Janneke Meulenberg | PRRSV vaccines |
US6555110B1 (en) | 1992-11-16 | 2003-04-29 | The Corporation Of Mercer University | Microencapsulated compounds and method of preparing same |
US6576264B1 (en) | 1995-10-17 | 2003-06-10 | Skyepharma Canada Inc. | Insoluble drug delivery |
US20030152538A1 (en) * | 2002-01-16 | 2003-08-14 | George Preti | Olfactory adaptation and cross-adapting agents to reduce the perception of body odors |
US20030157689A1 (en) * | 1998-12-22 | 2003-08-21 | Calvert Jay G. | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US6610348B2 (en) | 1997-02-17 | 2003-08-26 | Fonterra Tech Limited | Gelling agents and gels containing them |
US20030175347A1 (en) * | 2002-03-14 | 2003-09-18 | Steffier Larry W. | Durable film coating compositions having sustained slow-release capability, and methods of use therefor |
US20030194442A1 (en) * | 2000-09-20 | 2003-10-16 | Skyepharma Canada Inc | Insoluble drug particle compositions with improved fasted-fed effects |
US6634576B2 (en) | 2000-08-31 | 2003-10-21 | Rtp Pharma Inc. | Milled particles |
US6682761B2 (en) | 2000-04-20 | 2004-01-27 | Rtp Pharma, Inc. | Water-insoluble drug particle process |
US20040043079A1 (en) * | 1992-11-16 | 2004-03-04 | D'souza Martin J. | Microencapsulated materials and method of making same |
US20040086571A1 (en) * | 2001-02-22 | 2004-05-06 | Skyepharma Canada Inc. | Fibrate-statin combinations with reduced fed-fasted effects |
US20040091535A1 (en) * | 2000-09-20 | 2004-05-13 | Skyepharma Canada Inc. | Coated tablets |
US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
US20050095258A1 (en) * | 1999-02-17 | 2005-05-05 | Manuel Campos | Fusion proteins comprising carriers that can induce a dual immune response |
US6890888B2 (en) | 2000-07-03 | 2005-05-10 | Nft Industries, Llc | Controlled release agricultural products and processes for making same |
US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
US7041705B2 (en) | 1998-08-19 | 2006-05-09 | Jagotec Ag | Injectable aqueous dispersions of propofol |
US20060183113A1 (en) * | 1998-12-22 | 2006-08-17 | Calvert Jay G | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US20060210622A1 (en) * | 1999-09-21 | 2006-09-21 | Skyepharma Canada Inc. | Surface modified particulate compositions of biologically active substances |
US20070042000A1 (en) * | 1999-04-22 | 2007-02-22 | Mengeling William L | Porcine reproductive and respiratory syndrome vaccine based on isolate ja-142 |
US20070116720A1 (en) * | 1998-12-22 | 2007-05-24 | Calvert Jay G | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US20070197670A1 (en) * | 2006-02-23 | 2007-08-23 | International Business Machines Corporation | Rigidized compliant foam and method for implementing a rigidized compliant foam |
US20080233219A1 (en) * | 2005-08-31 | 2008-09-25 | Nature Technology Inc. | Composition for diet comprising plant essential oil as active ingredient, sheet type composition for diet comprising thereof, percutaneous pharmaceutical agent for diet comprising thereof, and method for producing thereof |
US20090078918A1 (en) * | 2007-09-25 | 2009-03-26 | Cary Michael Huettner | Methods and Structures With Fire Retardant Spheres for Implementing Enhanced Fire Protection |
US20090304896A1 (en) * | 2006-03-22 | 2009-12-10 | Nestec S.A. | Solid product comprising oil-droplets |
US20100035276A1 (en) * | 2004-06-18 | 2010-02-11 | Regents of of the University of Minnesota | Identifying virally infected and vaccinated organisms |
WO2010044889A2 (en) | 2008-10-16 | 2010-04-22 | Pfizer Inc. | Torque teno virus (ttv) isolates and compositions |
US20100111984A1 (en) * | 2008-09-29 | 2010-05-06 | The Corporation Of Mercer University | Nanospheres encapsulating bioactive material and method for formulation of nanospheres |
US20110059126A1 (en) * | 2009-09-02 | 2011-03-10 | Boehringer Ingelheim Vetmedica, Inc. | Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity |
US7939105B2 (en) | 1998-11-20 | 2011-05-10 | Jagotec Ag | Process for preparing a rapidly dispersing solid drug dosage form |
US20110117129A1 (en) * | 2008-08-25 | 2011-05-19 | Boehringer Ingelheim Vetmedica, Inc. | Vaccine Against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (HP PRRS) |
US20110195088A1 (en) * | 2004-09-21 | 2011-08-11 | Boehringer Ingelheim Vetmedica, Inc. | Porcine Reproductive and Respiratory Syndrome Isolates and Methods of Use |
US20120034337A1 (en) * | 2008-12-29 | 2012-02-09 | Friesland Brands B.V. | Protein particles and their use in food |
US8206746B2 (en) | 1996-08-22 | 2012-06-26 | Jagotec Ag | Microparticles of water-insoluble substances |
WO2012168818A1 (en) | 2011-06-08 | 2012-12-13 | Ah Usa 42 Llc | Infectious clones of torque teno virus |
US8415329B1 (en) | 1998-05-29 | 2013-04-09 | Jagotec Ag | Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations |
US8765142B2 (en) | 2011-02-17 | 2014-07-01 | Boehringer Ingelheim Vetmedica Gmbh | European PRRSV strain |
US8846388B2 (en) | 2009-10-16 | 2014-09-30 | Zoetis Llc | Infectious clones of torque teno virus |
US9080143B2 (en) | 2005-06-24 | 2015-07-14 | University Of Minnesota | PRRS viruses, infectious clones, mutants thereof, and method of use |
US20150250227A1 (en) * | 2010-03-26 | 2015-09-10 | Philip Morris Usa Inc. | Inhibition of sensory irritation during consumption of non-smokeable tobacco products |
US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
US9315781B2 (en) | 2011-07-29 | 2016-04-19 | Boehringer Ingelheim Vetmedica Gmbh | Infectious CDNA clone of european PRRS virus and uses thereof |
US9566324B2 (en) | 2010-11-10 | 2017-02-14 | Zoetis Services Llc | North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US9579373B2 (en) | 2013-03-15 | 2017-02-28 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
WO2017165366A1 (en) | 2016-03-21 | 2017-09-28 | South Dakota Board Of Regents | Orf virus-based platform for vaccine delivery |
US9944902B2 (en) | 2011-02-17 | 2018-04-17 | Boehringer Ingelheim Vetmedica Gmbh | Commercial scale process for production of PRRSV |
WO2018112169A2 (en) | 2016-12-14 | 2018-06-21 | Zoetis Services Llc | Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning |
US10004790B2 (en) | 2008-09-29 | 2018-06-26 | The Corporation Of Mercer University | Nanospheres encapsulating bioactive material and method for formulation of nanospheres |
US10010601B2 (en) | 2013-12-20 | 2018-07-03 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus variant, European PRRS virus cDNA clone, and uses thereof |
US10383934B2 (en) | 2010-11-10 | 2019-08-20 | Zoetis Services Llc | Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning |
US10463608B2 (en) | 2008-09-29 | 2019-11-05 | The Corporation Of Mercer University | Microneedle-based transdermal delivery system and method of making same |
US10849962B2 (en) | 2015-10-05 | 2020-12-01 | The Corporation Of Mercer University | Method and apparatus for microneedle transdermal delivery |
US10881129B2 (en) | 2017-08-10 | 2021-01-05 | Wisconsin Alumni Research Foundation | Coated egg yolk cores, methods of making and methods of use thereof |
WO2022072215A2 (en) | 2020-09-29 | 2022-04-07 | Zoetis Services Llc | Attenuated porcine epidemic diarrhea virus |
WO2022221612A1 (en) | 2021-04-16 | 2022-10-20 | Zortis Services Llc | Pseudorabies virus vaccine |
US11524058B2 (en) | 2008-09-29 | 2022-12-13 | The Corporation Of Mercer University | Oral dissolving films containing microencapsulated vaccines and methods of making same |
US11628208B2 (en) | 2015-10-05 | 2023-04-18 | The Corporation Of Mercer University | System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2491475A (en) * | 1946-03-25 | 1949-12-20 | Parke Davis & Co | Enteric capsule |
US2656298A (en) * | 1948-11-10 | 1953-10-20 | Jacques Loewe Res Foundation | Therapeutic product |
US2797201A (en) * | 1953-05-11 | 1957-06-25 | Standard Oil Co | Process of producing hollow particles and resulting product |
US2800457A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US2800458A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US2870062A (en) * | 1956-04-27 | 1959-01-20 | Scherer Corp R P | Gelatin composition for capsules |
US2969330A (en) * | 1958-06-04 | 1961-01-24 | Ncr Co | Oil containing capsules and method of making them |
US3041289A (en) * | 1959-01-02 | 1962-06-26 | Ncr Co | Method of making walled clusters of capsules |
-
1959
- 1959-12-01 US US856379A patent/US3137631A/en not_active Expired - Lifetime
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2491475A (en) * | 1946-03-25 | 1949-12-20 | Parke Davis & Co | Enteric capsule |
US2656298A (en) * | 1948-11-10 | 1953-10-20 | Jacques Loewe Res Foundation | Therapeutic product |
US2797201A (en) * | 1953-05-11 | 1957-06-25 | Standard Oil Co | Process of producing hollow particles and resulting product |
US2800457A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US2800458A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US2870062A (en) * | 1956-04-27 | 1959-01-20 | Scherer Corp R P | Gelatin composition for capsules |
US2969330A (en) * | 1958-06-04 | 1961-01-24 | Ncr Co | Oil containing capsules and method of making them |
US3041289A (en) * | 1959-01-02 | 1962-06-26 | Ncr Co | Method of making walled clusters of capsules |
Cited By (193)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3293114A (en) * | 1964-04-03 | 1966-12-20 | Dow Chemical Co | Method of forming paper containing gaseous filled spheres of thermoplastic resins and paper thereof |
US3406119A (en) * | 1965-03-05 | 1968-10-15 | Keuffel & Esser Co | Encapsulation |
US3384536A (en) * | 1965-03-24 | 1968-05-21 | Ncr Co | Process for forming fibrous sheets containing limited penetration of additaments within the sheet and sheets thereof |
US3257267A (en) * | 1965-05-19 | 1966-06-21 | Harold R Hay | Retarding liberation of an additament in forming a fibrous web by embedding the additament in a gel matrix prior to addition to the fibers |
US3516941A (en) * | 1966-07-25 | 1970-06-23 | Minnesota Mining & Mfg | Microcapsules and process of making |
US3886084A (en) * | 1966-09-29 | 1975-05-27 | Champion Int Corp | Microencapsulation system |
US3490454A (en) * | 1966-10-21 | 1970-01-20 | United Merchants & Mfg | Catamenial products having a coating of rupturable microcapsules containing medicants |
US3521637A (en) * | 1967-11-28 | 1970-07-28 | Nelson J Waterbury | Tampon or similar sanitary napkin containing vitamin a |
US3663685A (en) * | 1968-04-01 | 1972-05-16 | Minnesota Mining & Mfg | Biodegradable radioactive particles |
USRE29066E (en) * | 1968-04-01 | 1976-12-07 | Minnesota Mining And Manufacturing Company | Biodegradable radioactive particles |
US3515070A (en) * | 1968-05-15 | 1970-06-02 | Us Army | Chemiluminescent peraminoethylene positioned within a brittle capsule |
US3720579A (en) * | 1968-12-23 | 1973-03-13 | Champion Int Corp | Fibrous substrates with microcapsular opacifiers |
FR2033293A1 (en) * | 1969-02-04 | 1970-12-04 | Oreal | |
US3978204A (en) * | 1969-02-04 | 1976-08-31 | L'oreal | Cosmetic composition containing microencapsulated solvents for nail enamel |
US3669899A (en) * | 1969-04-29 | 1972-06-13 | Us Plywood Champ Papers Inc | Microcapsular opacifier system |
US3816169A (en) * | 1969-04-29 | 1974-06-11 | Champion Int Corp | Fibrous and non-fibrous substrates coated with microcapsular pacifier system and the production of such coated substrates |
US3516846A (en) * | 1969-11-18 | 1970-06-23 | Minnesota Mining & Mfg | Microcapsule-containing paper |
US3623659A (en) * | 1969-12-29 | 1971-11-30 | Ncr Co | Articles of manufacture containing encapsulated, vaporizable core material |
US3937668A (en) * | 1970-07-15 | 1976-02-10 | Ilse Zolle | Method for incorporating substances into protein microspheres |
US4273672A (en) * | 1971-08-23 | 1981-06-16 | Champion International Corporation | Microencapsulation process |
US3911099A (en) * | 1974-01-23 | 1975-10-07 | Defoney Brenman Mayes & Baron | Long-acting articles for oral delivery and process |
US4039653A (en) * | 1974-01-23 | 1977-08-02 | Defoney, Brenman, Mayes & Baron | Long-acting articles for oral delivery and process |
US3957964A (en) * | 1974-01-30 | 1976-05-18 | Colgate-Palmolive Company | Dentifrice containing encapsulated flavoring |
US4001480A (en) * | 1974-08-16 | 1977-01-04 | Swift & Company | Encapsulation process utilizing microorganisms and products produced thereby |
USB498208I5 (en) * | 1974-08-16 | 1976-04-13 | ||
US4138362A (en) * | 1975-03-24 | 1979-02-06 | Champion International Corporation | Formation of microcapsules by interfacial cross-linking, microcapsules produced, and microcapsular dispersion |
US4105823A (en) * | 1975-11-26 | 1978-08-08 | Wiggins Teape Limited | Microcapsules, method for their preparation, and sheet material carrying microcapsules |
US4145184A (en) * | 1975-11-28 | 1979-03-20 | The Procter & Gamble Company | Detergent composition containing encapsulated perfume |
US4184495A (en) * | 1976-04-07 | 1980-01-22 | Philip Morris, Inc. | Process for incorporating flavorant into cellulosic substrates and products produced thereby |
US4217369A (en) * | 1976-08-09 | 1980-08-12 | The Pillsbury Company | Moisture resistant nut-like food composition |
US4115534A (en) * | 1976-08-19 | 1978-09-19 | Minnesota Mining And Manufacturing Company | In vitro diagnostic test |
US4169804A (en) * | 1976-08-19 | 1979-10-02 | Minnesota Mining And Manufacturing Company | Magnetically responsive composite microparticle |
US4138505A (en) * | 1976-10-28 | 1979-02-06 | Blue Wing Corporation | Nutrient compositions derived from animal blood solids and process for producing same |
US4152272A (en) * | 1976-10-29 | 1979-05-01 | The Procter & Gamble Company | Fabric conditioning composition |
US4357259A (en) * | 1977-08-01 | 1982-11-02 | Northwestern University | Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres |
WO1979000111A1 (en) * | 1977-08-25 | 1979-03-08 | Blue Wing Corp | Improved lipid-containing feed supplements and foodstuffs |
US4217370A (en) * | 1977-08-25 | 1980-08-12 | Blue Wing Corporation | Lipid-containing feed supplements and foodstuffs |
FR2400850A2 (en) * | 1977-08-25 | 1979-03-23 | Blue Wing Corp | FOOD SUPPLEMENT CONTAINING FAT FOR ANIMAL FEEDING AND PROCESS OF PREPARATION |
US4225620A (en) * | 1977-08-26 | 1980-09-30 | Blue Wing Corporation | Method for feeding ruminant animals |
US4248899A (en) * | 1979-02-26 | 1981-02-03 | The United States Of America As Represented By The Secretary Of Agriculture | Protected feeds for ruminants |
USRE32713E (en) * | 1980-03-17 | 1988-07-12 | Capsule impregnated fabric | |
US4396670A (en) * | 1980-04-08 | 1983-08-02 | The Wiggins Teape Group Limited | Process for the production of microcapsules |
US4331654A (en) * | 1980-06-13 | 1982-05-25 | Eli Lilly And Company | Magnetically-localizable, biodegradable lipid microspheres |
US5332584A (en) * | 1980-10-30 | 1994-07-26 | Zeneca Inc. | Microcapsules |
US4349530A (en) * | 1980-12-11 | 1982-09-14 | The Ohio State University | Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal |
WO1982001994A1 (en) * | 1980-12-11 | 1982-06-24 | Univ Ohio | Implants,microbeads,microcapsules,and method for their preparation |
US4388352A (en) * | 1981-08-03 | 1983-06-14 | Board Of Regents, University Of Washington | Method for preparing a controlled release composition |
US4514461A (en) * | 1981-08-10 | 1985-04-30 | Woo Yen Kong | Fragrance impregnated fabric |
FR2526328A1 (en) * | 1982-05-04 | 1983-11-10 | Centre Nat Rech Scient | WALL MICROCAPSULES OBTAINED BY CROSSLINKING MILK PROTEINS, AND PROCESS FOR THE PREPARATION THEREOF |
EP0093668A1 (en) * | 1982-05-04 | 1983-11-09 | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) | Microcapsules having a wall of reticulately bound milk proteins, and method for their preparation |
US4798786A (en) * | 1982-05-06 | 1989-01-17 | Stolle Research And Development Corporation | Living cells encapsulated in crosslinked protein |
WO1984000304A1 (en) * | 1982-07-08 | 1984-02-02 | Mitchell Harman | Injectible sustained release dosage cylinders |
WO1985000011A1 (en) * | 1983-06-17 | 1985-01-03 | Univ Miami | Microdroplets of water-insoluble drugs |
US4956129A (en) * | 1984-03-30 | 1990-09-11 | Ici Americas Inc. | Microencapsulation process |
US4666641A (en) * | 1984-06-05 | 1987-05-19 | Universite Paris-Sud (Paris Xi) | Preparation of biodegradable microcapsules based on serum albumin |
US4608263A (en) * | 1984-09-11 | 1986-08-26 | The Quaker Oats Company | Method for making flavored dipeptide sweetened comestible |
US4660763A (en) * | 1985-09-11 | 1987-04-28 | S. C. Johnson & Son, Inc. | Vapor-dispensing device |
US4729792A (en) * | 1985-11-08 | 1988-03-08 | The Standard Register Company | Microcapsules, printing inks and their production |
US4898780A (en) * | 1985-11-08 | 1990-02-06 | The Standard Register Company | Production of microcapsules |
US4715390A (en) * | 1985-11-19 | 1987-12-29 | Philip Morris Incorporated | Matrix entrapment of flavorings for smoking articles |
US5023080A (en) * | 1988-06-17 | 1991-06-11 | Basic Bio Systems, Inc. | Time release protein |
US5055300A (en) * | 1988-06-17 | 1991-10-08 | Basic Bio Systems, Inc. | Time release protein |
EP0349428A1 (en) * | 1988-06-30 | 1990-01-03 | Centre National De La Recherche Scientifique (Cnrs) | Process for preparing colloidal dispersive protein systems in the shape of nanoparticles |
US5143737A (en) * | 1989-10-13 | 1992-09-01 | The Regents Of The University Of California | Method to produce unsaturated milk fat and meat from ruminant animals |
WO1991005482A1 (en) * | 1989-10-13 | 1991-05-02 | The Regents Of The University Of California | Method to produce unsaturated milk fat and meat from ruminant animals |
US5132117A (en) * | 1990-01-11 | 1992-07-21 | Temple University | Aqueous core microcapsules and method for their preparation |
US5383862A (en) * | 1990-02-03 | 1995-01-24 | Telemedysis Inc | Method and device for enveloping and disinfecting of sharp instruments |
US5074902A (en) * | 1990-07-30 | 1991-12-24 | Connick Jr William J | Granular products containing fungi encapsulated in a wheat gluten matrix for biological control of weeds |
US5418010A (en) * | 1990-10-05 | 1995-05-23 | Griffith Laboratories Worldwide, Inc. | Microencapsulation process |
US20090081306A1 (en) * | 1992-11-16 | 2009-03-26 | The Corporation Of Mercer University | Microencapsulated materials and method of making same |
US6555110B1 (en) | 1992-11-16 | 2003-04-29 | The Corporation Of Mercer University | Microencapsulated compounds and method of preparing same |
US7425543B2 (en) | 1992-11-16 | 2008-09-16 | The Corporation Of Mercer University | Microencapsulated materials and method of making same |
US20040043079A1 (en) * | 1992-11-16 | 2004-03-04 | D'souza Martin J. | Microencapsulated materials and method of making same |
US6090925A (en) * | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6268053B1 (en) | 1993-03-09 | 2001-07-31 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5578709A (en) * | 1993-03-09 | 1996-11-26 | Middlesex Sciences, Inc. | Macromolecular microparticles and methods of production |
US5607754A (en) * | 1993-11-12 | 1997-03-04 | Kimberly-Clark Corporation | Paper web product and method for manufacturing same |
US5549903A (en) * | 1994-03-03 | 1996-08-27 | Ben Gurion University Of Negev Research & Development Aurthority | Microencapsulated composition containing chlorpyrifos or endosulfsan |
US6531156B1 (en) | 1994-04-15 | 2003-03-11 | Temple University | Aqueous solven encapsulation method, apparatus and microcapsules |
US5686113A (en) * | 1995-03-21 | 1997-11-11 | Temple University Of The Commonwealth System Of Higher Education | Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses |
US6576264B1 (en) | 1995-10-17 | 2003-06-10 | Skyepharma Canada Inc. | Insoluble drug delivery |
US6974593B2 (en) | 1995-10-17 | 2005-12-13 | Jagotec Ag | Insoluble drug delivery |
US20040018229A1 (en) * | 1995-10-17 | 2004-01-29 | Henriksen Inge B. | Insoluble drug delivery |
US8206746B2 (en) | 1996-08-22 | 2012-06-26 | Jagotec Ag | Microparticles of water-insoluble substances |
US7255877B2 (en) | 1996-08-22 | 2007-08-14 | Jagotec Ag | Fenofibrate microparticles |
US20020119199A1 (en) * | 1996-08-22 | 2002-08-29 | Indu Parikh | Fenofibrate microparticles |
US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
US20040197872A1 (en) * | 1996-10-30 | 2004-10-07 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
US20060205033A1 (en) * | 1996-10-30 | 2006-09-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
US20060240041A1 (en) * | 1996-10-30 | 2006-10-26 | Meulenberg Johanna J M | PRRSV Vaccines |
US8546124B2 (en) | 1996-10-30 | 2013-10-01 | Boehringer Ingelheim Vetmedica Gmbh | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
US20020098573A1 (en) * | 1996-10-30 | 2002-07-25 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
US8790656B2 (en) | 1996-10-30 | 2014-07-29 | Boehringer Ingelheim Vetmedica Gmbh | PRRSV vaccines |
US6610348B2 (en) | 1997-02-17 | 2003-08-26 | Fonterra Tech Limited | Gelling agents and gels containing them |
US20030013693A1 (en) * | 1998-02-11 | 2003-01-16 | Rtp Pharma Inc. | Method and composition for treatment of inflammatory conditions |
US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
US8415329B1 (en) | 1998-05-29 | 2013-04-09 | Jagotec Ag | Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations |
US7097849B2 (en) | 1998-08-19 | 2006-08-29 | Jagotec Ag | Injectable aqueous dispersions of propofol |
US7041705B2 (en) | 1998-08-19 | 2006-05-09 | Jagotec Ag | Injectable aqueous dispersions of propofol |
US7939105B2 (en) | 1998-11-20 | 2011-05-10 | Jagotec Ag | Process for preparing a rapidly dispersing solid drug dosage form |
US7939106B2 (en) | 1998-11-20 | 2011-05-10 | Jagotec Ag | Process for preparing a rapidly dispersing solid drug dosage form |
US6500662B1 (en) | 1998-12-22 | 2002-12-31 | Pfizer Inc. | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US7618797B2 (en) | 1998-12-22 | 2009-11-17 | Pfizer Inc | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US7691389B2 (en) | 1998-12-22 | 2010-04-06 | Pfizer Inc | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
EP1627919A1 (en) | 1998-12-22 | 2006-02-22 | Pfizer Products Inc. | An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US8895025B2 (en) | 1998-12-22 | 2014-11-25 | Zoetis Llc | Infectious cDNA of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US20060183113A1 (en) * | 1998-12-22 | 2006-08-17 | Calvert Jay G | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US8609827B2 (en) | 1998-12-22 | 2013-12-17 | Zoetis Llc | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US8492132B2 (en) | 1998-12-22 | 2013-07-23 | Zoetis Llc | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PPRS) virus and uses thereof |
US7232680B2 (en) | 1998-12-22 | 2007-06-19 | Pfizer Inc. | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US20020172690A1 (en) * | 1998-12-22 | 2002-11-21 | Calvert Jay G. | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US8481705B2 (en) | 1998-12-22 | 2013-07-09 | Zoetis Llc | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US7132106B2 (en) | 1998-12-22 | 2006-11-07 | Pfizer Inc. | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US20070116720A1 (en) * | 1998-12-22 | 2007-05-24 | Calvert Jay G | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US20030157689A1 (en) * | 1998-12-22 | 2003-08-21 | Calvert Jay G. | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US20050095258A1 (en) * | 1999-02-17 | 2005-05-05 | Manuel Campos | Fusion proteins comprising carriers that can induce a dual immune response |
US6911206B1 (en) | 1999-02-17 | 2005-06-28 | Pfizer Inc. | Fusion proteins comprising carriers that can induce a dual immune response |
US20030049274A1 (en) * | 1999-03-08 | 2003-03-13 | Janneke Meulenberg | PRRSV vaccines |
US6174514B1 (en) * | 1999-04-12 | 2001-01-16 | Fuisz Technologies Ltd. | Breath Freshening chewing gum with encapsulations |
US20070042000A1 (en) * | 1999-04-22 | 2007-02-22 | Mengeling William L | Porcine reproductive and respiratory syndrome vaccine based on isolate ja-142 |
US20110104201A1 (en) * | 1999-04-22 | 2011-05-05 | Mengeling William L | Porcine Reproductive and Respiratory Syndrome Vaccine Based on Isolate JA-142 |
US8741309B2 (en) | 1999-04-22 | 2014-06-03 | The United States Of America As Represented By The Secretary Of Agriculture | Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142 |
US8747859B2 (en) | 1999-04-22 | 2014-06-10 | The United States Of America, As Represented By The Secretary Of Agriculture | Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142 |
US20060210622A1 (en) * | 1999-09-21 | 2006-09-21 | Skyepharma Canada Inc. | Surface modified particulate compositions of biologically active substances |
US6682761B2 (en) | 2000-04-20 | 2004-01-27 | Rtp Pharma, Inc. | Water-insoluble drug particle process |
US20090258786A1 (en) * | 2000-07-03 | 2009-10-15 | Taylor Pursell | Controlled release agricultural products and processes for making the same |
US6890888B2 (en) | 2000-07-03 | 2005-05-10 | Nft Industries, Llc | Controlled release agricultural products and processes for making same |
US20050107259A1 (en) * | 2000-07-03 | 2005-05-19 | Taylor Pursell | Controlled release agricultural products and processes for making same |
US6634576B2 (en) | 2000-08-31 | 2003-10-21 | Rtp Pharma Inc. | Milled particles |
US20040091535A1 (en) * | 2000-09-20 | 2004-05-13 | Skyepharma Canada Inc. | Coated tablets |
US8586094B2 (en) | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
US8703202B2 (en) | 2000-09-20 | 2014-04-22 | Jagotec Ag | Coated tablets |
US20060257494A1 (en) * | 2000-09-20 | 2006-11-16 | Michael Vachon | Coated tablets |
US20030194442A1 (en) * | 2000-09-20 | 2003-10-16 | Skyepharma Canada Inc | Insoluble drug particle compositions with improved fasted-fed effects |
US20040086571A1 (en) * | 2001-02-22 | 2004-05-06 | Skyepharma Canada Inc. | Fibrate-statin combinations with reduced fed-fasted effects |
US20030152538A1 (en) * | 2002-01-16 | 2003-08-14 | George Preti | Olfactory adaptation and cross-adapting agents to reduce the perception of body odors |
US7763238B2 (en) * | 2002-01-16 | 2010-07-27 | Monell Chemical Senses Center | Olfactory adaptation and cross-adapting agents to reduce the perception of body odors |
US8684739B2 (en) | 2002-03-14 | 2014-04-01 | Mycone Dental Supply Co., Inc. | Durable film coating compositions having sustained slow-release capability, and methods of use therefor |
US8668930B2 (en) | 2002-03-14 | 2014-03-11 | Mycone Dental Supply Co., Ltd. | Durable film coating compositions having sustained slow-release capability, and methods of use therefor |
US20030175347A1 (en) * | 2002-03-14 | 2003-09-18 | Steffier Larry W. | Durable film coating compositions having sustained slow-release capability, and methods of use therefor |
US20060198890A1 (en) * | 2002-03-14 | 2006-09-07 | Keystone Industries | Durable film coating compositions having sustained slow-release capability, and methods of use therefor |
US20100035276A1 (en) * | 2004-06-18 | 2010-02-11 | Regents of of the University of Minnesota | Identifying virally infected and vaccinated organisms |
US8399187B2 (en) | 2004-06-18 | 2013-03-19 | Regents Of The University Of Minnesota | Identifying virally infected and vaccinated organisms |
US20110195088A1 (en) * | 2004-09-21 | 2011-08-11 | Boehringer Ingelheim Vetmedica, Inc. | Porcine Reproductive and Respiratory Syndrome Isolates and Methods of Use |
US8383131B2 (en) | 2004-09-21 | 2013-02-26 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
US9080143B2 (en) | 2005-06-24 | 2015-07-14 | University Of Minnesota | PRRS viruses, infectious clones, mutants thereof, and method of use |
US20080233219A1 (en) * | 2005-08-31 | 2008-09-25 | Nature Technology Inc. | Composition for diet comprising plant essential oil as active ingredient, sheet type composition for diet comprising thereof, percutaneous pharmaceutical agent for diet comprising thereof, and method for producing thereof |
US20070197670A1 (en) * | 2006-02-23 | 2007-08-23 | International Business Machines Corporation | Rigidized compliant foam and method for implementing a rigidized compliant foam |
US8147896B2 (en) * | 2006-03-22 | 2012-04-03 | Nestec S.A. | Solid product comprising oil-droplets |
US20090304896A1 (en) * | 2006-03-22 | 2009-12-10 | Nestec S.A. | Solid product comprising oil-droplets |
US20090078918A1 (en) * | 2007-09-25 | 2009-03-26 | Cary Michael Huettner | Methods and Structures With Fire Retardant Spheres for Implementing Enhanced Fire Protection |
US20110117129A1 (en) * | 2008-08-25 | 2011-05-19 | Boehringer Ingelheim Vetmedica, Inc. | Vaccine Against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (HP PRRS) |
US10463608B2 (en) | 2008-09-29 | 2019-11-05 | The Corporation Of Mercer University | Microneedle-based transdermal delivery system and method of making same |
US10786558B2 (en) | 2008-09-29 | 2020-09-29 | The Corporation Of Mercer University | Oral dissolving films |
US9149441B2 (en) | 2008-09-29 | 2015-10-06 | The Corporation Of Mercer University | Nanospheres encapsulating bioactive material and method for formulation of nanospheres |
US20100111984A1 (en) * | 2008-09-29 | 2010-05-06 | The Corporation Of Mercer University | Nanospheres encapsulating bioactive material and method for formulation of nanospheres |
US11524058B2 (en) | 2008-09-29 | 2022-12-13 | The Corporation Of Mercer University | Oral dissolving films containing microencapsulated vaccines and methods of making same |
US10004790B2 (en) | 2008-09-29 | 2018-06-26 | The Corporation Of Mercer University | Nanospheres encapsulating bioactive material and method for formulation of nanospheres |
US8969536B2 (en) | 2008-10-16 | 2015-03-03 | Zoetis Llc | Torque teno virus (TTV) isolates and compositions |
US8921535B2 (en) | 2008-10-16 | 2014-12-30 | Zoetis Llc | Infectious clones of torque teno virus |
WO2010044889A2 (en) | 2008-10-16 | 2010-04-22 | Pfizer Inc. | Torque teno virus (ttv) isolates and compositions |
US20110064758A1 (en) * | 2008-10-16 | 2011-03-17 | Pfizer Inc. | Infectious clones of torque teno virus |
US20110150913A1 (en) * | 2008-10-16 | 2011-06-23 | Pfizer Inc. | Torque teno virus (ttv) isolates and compositions |
US20120034337A1 (en) * | 2008-12-29 | 2012-02-09 | Friesland Brands B.V. | Protein particles and their use in food |
US20110059126A1 (en) * | 2009-09-02 | 2011-03-10 | Boehringer Ingelheim Vetmedica, Inc. | Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity |
US9561270B2 (en) | 2009-09-02 | 2017-02-07 | Boehringer Ingelheim Vetmedica, Inc. | Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity |
US8846388B2 (en) | 2009-10-16 | 2014-09-30 | Zoetis Llc | Infectious clones of torque teno virus |
US20150250227A1 (en) * | 2010-03-26 | 2015-09-10 | Philip Morris Usa Inc. | Inhibition of sensory irritation during consumption of non-smokeable tobacco products |
US11129405B2 (en) | 2010-03-26 | 2021-09-28 | Philip Morris Usa Inc. | Inhibition of sensory irritation during consumption of non-smokeable tobacco products |
US10117453B2 (en) * | 2010-03-26 | 2018-11-06 | Philip Morris Usa Inc. | Inhibition of sensory irritation during consumption of non-smokeable tobacco products |
US11351239B2 (en) | 2010-11-10 | 2022-06-07 | Zoetis Services Llc | Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning |
US10383934B2 (en) | 2010-11-10 | 2019-08-20 | Zoetis Services Llc | Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning |
US9566324B2 (en) | 2010-11-10 | 2017-02-14 | Zoetis Services Llc | North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US9944902B2 (en) | 2011-02-17 | 2018-04-17 | Boehringer Ingelheim Vetmedica Gmbh | Commercial scale process for production of PRRSV |
US8765142B2 (en) | 2011-02-17 | 2014-07-01 | Boehringer Ingelheim Vetmedica Gmbh | European PRRSV strain |
US10668144B2 (en) | 2011-02-17 | 2020-06-02 | Boehringer Ingelheim Vetmedica Gmbh | European PRRSV strain |
WO2012168818A1 (en) | 2011-06-08 | 2012-12-13 | Ah Usa 42 Llc | Infectious clones of torque teno virus |
US9315781B2 (en) | 2011-07-29 | 2016-04-19 | Boehringer Ingelheim Vetmedica Gmbh | Infectious CDNA clone of european PRRS virus and uses thereof |
US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
US10610581B2 (en) | 2012-05-17 | 2020-04-07 | Zoetis Services Llc | Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning |
US11351244B2 (en) | 2012-05-17 | 2022-06-07 | Zoetis Services Llc | Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning |
US9579373B2 (en) | 2013-03-15 | 2017-02-28 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
US10639364B2 (en) | 2013-12-20 | 2020-05-05 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus variant, european PRRS virus cDNA clone, and uses thereof |
US10010601B2 (en) | 2013-12-20 | 2018-07-03 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus variant, European PRRS virus cDNA clone, and uses thereof |
US10849962B2 (en) | 2015-10-05 | 2020-12-01 | The Corporation Of Mercer University | Method and apparatus for microneedle transdermal delivery |
US11628208B2 (en) | 2015-10-05 | 2023-04-18 | The Corporation Of Mercer University | System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins |
WO2017165366A1 (en) | 2016-03-21 | 2017-09-28 | South Dakota Board Of Regents | Orf virus-based platform for vaccine delivery |
US11090376B2 (en) | 2016-12-14 | 2021-08-17 | Zoetis Services Llc | Effective vaccination against European strains of porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning |
WO2018112169A2 (en) | 2016-12-14 | 2018-06-21 | Zoetis Services Llc | Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning |
US10881129B2 (en) | 2017-08-10 | 2021-01-05 | Wisconsin Alumni Research Foundation | Coated egg yolk cores, methods of making and methods of use thereof |
US11445742B2 (en) | 2017-08-10 | 2022-09-20 | Wisconsin Alumni Research Foundation | Coated egg yolk cores, methods of making and methods of use thereof |
WO2022072215A2 (en) | 2020-09-29 | 2022-04-07 | Zoetis Services Llc | Attenuated porcine epidemic diarrhea virus |
WO2022221612A1 (en) | 2021-04-16 | 2022-10-20 | Zortis Services Llc | Pseudorabies virus vaccine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3137631A (en) | Encapsulation in natural products | |
US3755190A (en) | Capsule manufacture | |
EP1531927B1 (en) | Process for the preparation of flavor or fragrance microcapsules | |
US3780195A (en) | Encapsulation process | |
US3585149A (en) | Microcapsular opacifier system | |
EP1196533B1 (en) | Improved encapsulated oil particles | |
JP3616009B2 (en) | Flavor and fragrance encapsulation method by controlled water transfer into microcapsules | |
US3781230A (en) | Microcapsular opacifier system | |
US3201353A (en) | Micro-inclusions and method of making same | |
DE29924358U1 (en) | Nano and micro capsules with a polyelectrolyte shell made of several polyelectrolyte layers | |
Shinde et al. | Microencapsulation of eugenol by gelatin-sodium alginate complex coacervation | |
US3743604A (en) | Process for the production of microcapsules | |
JPS5813212B2 (en) | Microcapsules | |
JPS5916821A (en) | Preparation of nonflocculating microcapsule | |
JPH0230736B2 (en) | ||
JPS63178840A (en) | Slowly-releasable microcapsule | |
JPH06503259A (en) | Method for producing collagen particles and their use as carriers for active substrates | |
US3549555A (en) | Encapsulation of lipophilic liquid-in-hydrophilic liquid emulsions | |
US3816169A (en) | Fibrous and non-fibrous substrates coated with microcapsular pacifier system and the production of such coated substrates | |
JPH021798A (en) | Lubricant-containing microcapsule and production thereof | |
JP3194768B2 (en) | Microcapsule and method for producing the same | |
US3317434A (en) | Method of encapsulating particulate matter by coacervation using gelatins of opposite isoionic ph | |
JPH02280828A (en) | Dry powder-like microcapsule particles, carriers carrying them, and manufacture thereof | |
US4000345A (en) | Substrate having coating thereon comprising microcapsular opacifying agents, and method of preparing same | |
US3752698A (en) | Substrates coated with air-containing microcapsular opacifiers and the production thereof |